In NSCLC, specific CAF subsets such as CAF7 (PDGFRA−/PDGFRB+/FAP+) were correlated with poor prognosis and immune suppression, while CAF13 (PDGFRA+/PDGFRB+/FAP−) was associated with favorable outcomes in EGFR‐mutant tumors [101]. Here, PDGFRB is linked to non-small cell lung carcinoma.